These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3702529)

  • 1. [How do we use theophyllines?].
    Gea J; Ballester E; Montserrat JM; Mayordomo C; Picado C; Agustí Vidal A
    Med Clin (Barc); 1986 Mar; 86(9):366-8. PubMed ID: 3702529
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dosage of slow-release theophyllines: analysis of plasma levels].
    Escarrabill J; Sabater I; Barragán F; Estopá R
    Med Clin (Barc); 1985 Jun; 85(2):81. PubMed ID: 4021619
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the pharmacokinetics of theophylline in asthmatic patients following multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Yamaki K; Satake T; Hasegawa T; Ogura Y; Suzuki R; Mizukami Y
    Arerugi; 1985 Nov; 34(11):1006-14. PubMed ID: 4084062
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum theophylline levels in adult asthmatics: comparison of oral sustained-release and microcrystalline preparations.
    Jones DT; Sears MR
    N Z Med J; 1980 Sep; 92(667):196-8. PubMed ID: 6933358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline and its fickle unpredictability of absorption.
    Szefler SJ
    Ann Allergy; 1985 Oct; 55(4):580-3. PubMed ID: 3901834
    [No Abstract]   [Full Text] [Related]  

  • 8. Nocturnal theophylline plasma concentrations.
    Jonkman JH; van der Boon WJ
    Lancet; 1983 Jun; 1(8336):1278-9. PubMed ID: 6134069
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
    van der Vet AP; Drost RH; Kreukniet J; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transition from parenteral to oral theophylline therapy in asthmatic patients].
    Mayer L
    Fortschr Med; 1985 Oct; 103(39):923-6. PubMed ID: 4065791
    [No Abstract]   [Full Text] [Related]  

  • 11. Simple method for intravenous-to-oral theophylline dose conversion.
    Wightkin WT; Buchhammer CR
    Clin Pharm; 1982; 1(4):300-1. PubMed ID: 7185527
    [No Abstract]   [Full Text] [Related]  

  • 12. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the pharmacokinetics of theophylline and its effect on respiratory impedance in asthmatic patients after multiple oral dosing of a sustained-release theophylline tablet formulation.
    Takagi K; Nosaka H; Satake T; Hasegawa T; Ogura Y; Mizukami Y
    Arerugi; 1986 May; 35(5):320-8. PubMed ID: 3753206
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of circadian variation in serum theophylline levels in the sustained-release theophylline treatment of chronic asthma].
    Watanabe A; Urata C; Nomoto H; Mizobe M; Abe Y; Mano K; Miyamato Y; Sano Y
    Arerugi; 1986 Jul; 35(7):447-54. PubMed ID: 3778214
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of plasma concentration determinations: theophylline.
    Weibert R
    Clin Toxicol; 1979; 14(2):157-60. PubMed ID: 436390
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative in vitro and in vivo study of several long-acting theophyllines].
    Blaive B; Lemoigne F; Macone F; Bugnas B; Garraffo R; Lapalus P
    Bull Eur Physiopathol Respir; 1986; 22(6):523-9. PubMed ID: 3828542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
    Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
    Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.